Shandong Weigao Blood Purification Products Co., Ltd. (SHA:603014)
China · Delayed Price · Currency is CNY 32.97
+0.77 (2.39%)
Aug 3, 2026, 4:00 PM EDT
SHA:603014 Market Cap
SHA:603014 has a market cap or net worth of 14.1 billion as of August 4, 2026. Its market cap has decreased by -13.04% in one year.
Market Cap
14.10B
Enterprise Value
11.33B
Revenue
3.78B
Ranking
n/a
PE Ratio
28.15
Stock Price
32.97
ChartMarket Cap Chart
Since May 19, 2025, SHA:603014's market cap has decreased from 17.04B to 14.10B, a decrease of -17.26%. That is a compound annual growth rate of -14.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 13.77B | -16.81% |
| Dec 31, 2025 | 16.56B | -2.82% |
| May 19, 2025 | 17.04B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MGI Tech | 20.55B |
| Autobio Diagnostics | 18.92B |
| Double Medical Technology | 17.66B |
| Jafron Biomedical | 14.40B |
| MeHow Innovative | 12.51B |
| Cofoe Medical Technology | 11.76B |
| Beijing Balance Medical Technology | 11.32B |
| Shanghai MicroPort Endovascular MedTech | 11.29B |